{"id":963167,"date":"2026-05-14T17:08:14","date_gmt":"2026-05-14T21:08:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cibus-reports-first-quarter-financial-results-and-provides-business-update\/"},"modified":"2026-05-14T17:08:14","modified_gmt":"2026-05-14T21:08:14","slug":"cibus-reports-first-quarter-financial-results-and-provides-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cibus-reports-first-quarter-financial-results-and-provides-business-update\/","title":{"rendered":"Cibus Reports First Quarter Financial Results and Provides Business Update"},"content":{"rendered":"
\n

SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), <\/strong>a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March\u00a031, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET.<\/p>\n

\n Management Commentary<\/strong>\n <\/p>\n

Peter Beetham, Interim Chief Executive Officer of Cibus, commented, “We are pleased to report continued momentum across our priority programs during the first quarter of 2026. We continue to work with our global seed company partners to change the scale and speed of breeding. Our Rice herbicide tolerance program is advancing on multiple fronts, including meaningful progress toward commercialization with our Latin American seed partners, including initially Interoc, as we continue to eye our targeted 2027 initial launch. Additionally, positive regulatory momentum continues to build around the world. For example, in April this year the Council of the European Union confirmed the agreed legislative text regulating New Genomic Techniques (NGTs), with that text now before the European Parliament for a plenary vote currently planned for an upcoming session. Combined with growing traction and an exciting expansion of activities leading to increased R&D funding in our Sustainable Ingredients program, these developments give us confidence in the near-term commercial potential of our platform and our ability to deliver tangible value to customers.”<\/p>\n

Mr. Beetham continued, “Today’s agricultural landscape underscores the urgency of our mission. Ongoing disruptions in global fertilizer supply chains, including reduced nitrogen production and delivery, are creating real challenges for farmers worldwide\u2014particularly in nitrogen-intensive crops like Rice, Wheat, and Canola. At Cibus, we are well positioned to help address agricultural challenges. While we are maintaining our near-term focus on Rice herbicide tolerance and Sustainable Ingredients, the current global agricultural environment highlights the significant value potential embedded across our broader opportunity pipeline\u2014from Canola disease resistance to Wheat platform development\u2014and reinforces why novel precision breeding solutions are essential to building a more resilient and productive agricultural system.”<\/p>\n

Carlo Broos, Chief Financial Officer of Cibus, commented, “Beyond our progress toward commercialization, we are executing well with respect to our cost discipline commitments of reducing operating expenses, and we are on track to deliver annual net cash usage of approximately $30 million or less in 2026. At the same time, revenue increased year-over-year, reflecting progressing activities and timing of payments across our programs. Combined with approximately $33 million in net proceeds raised from sales of equity during the quarter, we believe we are well-positioned to fund the advancement of our priority programs toward their near-term commercial milestones.”<\/p>\n

\n Company Highlights<\/strong>\n <\/p>\n